drugset
drugset / Trial / NCT02124005

Evaluation of the Minimum Effective Concentration of Bupivacaine (EC50) in Femoral Block for Analgesia by Ultrasound After Knee Surgery

NCT02124005 ↗

Phase 4 Completed 45 enrolled Ed Carlos Rey Moura
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to determine the minimum effective concentration of bupivacaine (EC50) in femoral block for analgesia by ultrasound after knee surgery.

Timeline

Start
2013-07
Primary completion
2015-07
Completion
2015-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 0.25 % Other
Subject Bupivacaine Other / unclassified 22 ml Other

Indications

osteoarthritis, knee